2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$2.44+$0.04 (+1.67%)
Price as of Oct 22, 2026 6:16 PM EDT- $523.0MMarket Cap
- -29.20%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$2.44+$0.04 (+1.67%)
Earnings Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 20 |
Momentum Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -14.04% | ||
12-Month Momentum | -18.67% | ||
3-Month Risk Adjusted Momentum | -51.00% | ||
12-Month Risk Adjusted Momentum | -21.90% |
True Yield
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 3.80% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |